Solve Therapeutics, Inc.

Form D Filings

Location
Belmont, CA
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0001905252
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
11/24/2025 Equity $48,214,232 $120,535,618 $72,321,386 11/14/2025 11/24/2025 D 000123191925000548
12/26/2024 Equity $50,388,557 $75,582,822 $25,194,265 12/13/2024 12/26/2024 D 000190525224000001
1/21/2022 Equity $63,510,835 $126,510,820 $62,999,985 12/17/2021 1/21/2022 D 000190525222000001